Procoagulant imbalance in patients with non-cirrhotic Chronic hepatitis C (CHC) improves six months after eradication with direct-acting antiviral agents (DAAs) and likely correlates with liver fibrosis

Autor:	Flora Peyvandi, Giuseppina Pisano, G. Sigon, Roberta D'Ambrosio, Pietro Lampertico, A.L. Fracanzani, Marigrazia Clerici, Armando Tripodi, R. Sollazzi, Veena Chantarangkul, Rossana Lombardi
Rok vydání:	2020
Předmět:	medicine.medical_specialty Hepatology Chronic hepatitis business.industry Liver fibrosis Internal medicine Gastroenterology Medicine In patient business Direct acting
Zdroj:	Digestive and Liver Disease. 52:e1-e2
ISSN:	1590-8658
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::37024bf8449f29c0fcd1d1fe7ef726c2 https://doi.org/10.1016/j.dld.2019.12.012 Zobrazit plný text záznamu Full Text from ScienceDirect